The Prodigiosins: A New Family of Anticancer Drugs

Publisher： Bentham Science Publishers

E-ISSN： 1873-5576|3|1|57-65

ISSN： 1568-0096

Source： Current Cancer Drug Targets, Vol.3, Iss.1, 2003-02, pp. : 57-65

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Safety profile of new anticancer drugs

By Mansi Laura   Thiery-Vuillemin Antoine   Nguyen Thierry   Bazan Fernando   Calcagno Fabien   Rocquain Julien   Demarchi Martin   Villanueva Cristian   Maurina Tristan   Pivot Xavier  

Expert Opinion on Drug Safety, Vol. 9, Iss. 2, 2010-03 ,pp. : 301-317

Informa Healthcare

Access to resources Recommend Favorite

Design of New Oxazaphosphorine Anticancer Drugs

By  

Current Pharmaceutical Design, Vol. 13, Iss. 9, 2007-03 ,pp. : 963-978

Bentham Science Publishers

Access to resources Recommend Favorite

Geminin as A Molecular Target for the Development of New Anticancer Drugs

By  

Mini Reviews in Medicinal Chemistry, Vol. 6, Iss. 4, 2006-04 ,pp. : 461-462

Bentham Science Publishers

Access to resources Recommend Favorite

New Anticancer Drugs from Marine Cyanobacteria

By  

Current Drug Targets, Vol. 13, Iss. 8, 2012-07 ,pp. : 1048-1053

Bentham Science Publishers

Access to resources Recommend Favorite

Nanocarriers for Anticancer Drugs - New Trends in Nanomedicine

By  

Current Drug Metabolism, Vol. 14, Iss. 5, 2013-06 ,pp. : 547-564

Bentham Science Publishers

Access to resources Recommend Favorite